The Company develops, manufactures, licenses and markets a range of products serving the aesthetic market, including plastic and reconstructive surgery.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Control 50% market share for breast implants, including the new silicon implants. Other cosmetic medical products to supply our fragile ego's. Stock will continue to rise as we work ourselves out of this recession and once again get to spend extra money on things that really matter like breast implants.